Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 13, 2023

BUY
$0.57 - $1.16 $1,271 - $2,586
2,230 Added 12.92%
19,496 $12,000
Q1 2023

May 11, 2023

BUY
$1.06 - $1.97 $1,328 - $2,468
1,253 Added 7.82%
17,266 $19,000
Q4 2022

Feb 08, 2023

BUY
$1.4 - $25.4 $22,418 - $406,730
16,013 New
16,013 $23,000
Q4 2021

Feb 03, 2022

SELL
$29.9 - $61.2 $494,605 - $1.01 Million
-16,542 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$51.4 - $68.2 $244,047 - $323,813
-4,748 Reduced 22.3%
16,542 $0
Q2 2021

Aug 10, 2021

BUY
$44.1 - $84.0 $73,867 - $140,700
1,675 Added 8.54%
21,290 $0
Q1 2021

May 07, 2021

BUY
$47.0 - $155.7 $921,905 - $3.05 Million
19,615 New
19,615 $0
Q4 2020

Feb 04, 2021

SELL
$4.8 - $30.8 $55,680 - $357,280
-11,600 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$4.7 - $8.9 $54,520 - $103,240
11,600 New
11,600 $0

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.